News

Beam reports positive results from sickle cell disease treatment
Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.
Sickle cell disease cured? Ohio State celebrates big win via innovative gene therapy
Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.
Beam Therapeutics Announces New Data From BEACON Phase 1/2 Clinical Trial Of BEAM-101 Supporting Differentiated Profile In Sickle Cell Disease (SCD) At European Hematology ...
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of ...